Trevi Therapeutics Inc (TRVI)
US Market

Trevi Therapeutics (TRVI) Financial Statements


Trevi Therapeutics Financial Overview

Trevi Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.27; its P/E ratio is -10.82; Trevi Therapeutics is scheduled to report earnings on March 20, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -7.71M$ -7.02M$ -7.40M$ -6.36M$ -8.07M
EBITDA-$ -7.38M$ -7.97M$ -6.80M$ -8.06M
Net Income Common Stockholders$ -7.70M$ -7.14M$ -6.40M$ -5.50M$ -8.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 88.87M$ 94.15M$ 111.26M$ 120.51M$ 125.60M
Total Assets$ 95.90M$ 100.98M$ 115.96M$ 123.02M$ 128.36M
Total Debt$ 1.41M$ 1.47M$ 9.02M$ 9.18M$ 10.86M
Net Debt$ -87.46M$ -92.68M$ -102.24M$ -111.33M$ -114.74M
Total Liabilities$ 6.29M$ 5.90M$ 14.47M$ 15.56M$ 18.46M
Stockholders Equity$ 89.61M$ 95.07M$ 101.73M$ 107.46M$ 109.90M
Cash Flow-
Free Cash Flow-$ -9.91M$ -8.25M$ -6.45M$ -8.62M
Operating Cash Flow$ -7.28M$ -9.88M$ -8.20M$ -6.33M$ -8.58M
Investing Cash Flow$ 17.98M$ 19.64M$ 8.96M$ -48.31M$ -4.85M
Financing Cash Flow$ 1.51M$ -7.66M$ -1.70M$ 652.00K$ 55.30M
Currency in USD

Trevi Therapeutics Earnings and Revenue History

Trevi Therapeutics Debt to Assets

Trevi Therapeutics Cash Flow

Trevi Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis